J. Vinke

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.

M. Venturini, Andrea Michelotti, Lucia Del Mastro et al. · Journal of Clinical Oncology · 1996 · 162 citations

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Prognostic Factors, Urology, Genitourinary Cancer +7

Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study

Jean-Claude Horiot, F. Lipinski, S Schraub et al. · Radiotherapy and Oncology · 2000 · 100 citations

Radiation Medicine, Radiation Therapy, Medicine +6

The Impact of Interleukin-2 on Survival in Renal Cancer: A Multivariate Analysis

Monica Jones, Thierry Philip, Peter Palmer et al. · Cancer Biotherapy · 1993 · 79 citations

Urology, Renal Function, Genitourinary Cancer +15

Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.

Sylvie Négrier, J Maral, M Drevon et al. · PubMed · 2000 · 61 citations